Carotid disease and the eye

Current Opinion in Ophthalmology

Volumn 8, Issue 6, 1997, Pages 16-26

  Biousse, Valérie ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CENTRAL RETINA ARTERY OCCLUSION; HORNER SYNDROME; HUMAN; ISCHEMIC OPTIC NEUROPATHY; OPHTHALMOPLEGIA; PRIORITY JOURNAL; RETINOPATHY; REVIEW; STROKE; VENOUS STASIS; VISUAL IMPAIRMENT;

ANIMALS; CAROTID ARTERY DISEASES; EYE; EYE DISEASES; HUMANS; ISCHEMIA;

EID: 0031467794     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199712000-00004     Document Type: Review

References (49)

1. Fisher CM: Observations of the fundus oculi in transient monocular blindness. Neurology 1959, 9:333-347.
2. Estol CJ: Dr. C. Miller Fisher and the history of carotid artery disease. Stroke 1996, 27:559-566. Historical review for those who forgot that the association between transient monocular blindness and ipsilateral carotid artery disease was first emphasized by Fisher, and that he was also the first to provide evidence of an embolic etiology in attacks of transient monocular blindness.
3. Ross Russell RW: Observations of the retinal blood vessels in monocular blindness. Lancet 1961, 2:1422-1428.
4. Hollenhorst RW: Significance of bright plaques in the retinal arterioles. JAMA 1961, 178:23-29.
5. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995, 273:1421-1428. The Asymptomatic Carotid Atherosclerosis Study (ACAS) trial is a prospective multicenter randomized trial of carotid endarterectomy in patients with asymptomatic carotid stenosis (greater than 60% reduction in lumen diameter) that was conducted at 39 clinical centers in the United States and Canada from 1987 to 1994. In this study, 1662 eligible patients, among 42,000 patients screened (4%), were randomized: 828 to the surgical group (carotid endarterectomy plus risk factor modification plus 325 mg aspirin per day), and 834 to the medical group (risk factor modification and 325 mg aspirin per day). The primary outcome events were stroke or death in the perioperative period, and stroke during follow-up. Transient ischemic attack [TIA] was not an outcome event; therefore, the results do not mention the number of patients who eventually experienced episodes of transient monocular visual loss during follow-up.) After a median follow-up of 2.7 years, cumulative risk (estimated risk) over 5 years of any perioperative stroke or death and of ipsilateral stroke during follow-up was estimated to be 11% for medical group patients and 5.1% for surgical group patients, a 5.9% absolute risk reduction, and a 53% relative risk reduction in the surgical group over 5 years. The authors concluded that "the incidence of cerebral infarction can be reduced by carotid endarterectomy." This apparently straightforward result has provoked considerable controversy, however.
6. Lanska DJ, Kryscio RJ: Endarterectomy for asymptomatic internal carotid artery stenosis. Neurology 1997, 48:1481-1490. This editorial reviews all the trials conducted to test the efficacy of endarterectomy for asymptomatic carotid artery stenosis, as well as controversies.
7. Bruno A, Russell PW, Jones WL, Austin JK, Weinstein ES, Steel SR: Concomitants of asymptomatic retinal cholesterol emboli. Stroke 1992, 23:900-902. In this US case-control consecutive study of 70 men with asymptomatic retinal emboli and 21 control subjects, asymptomatic retinal cholesterol emboli were found to have significant associations with hypertension, smoking, and the presence of heterogeneous carotid plaques on ultrasonogram.
8. ••]) for a mean period of 3.4 years, and revealed a 10-fold increase in the annual rate of stroke in the case subjects compared with a second group of 70 matched control subjects without emboli or ocular ischemia. The stroke risk was independent of other vascular risk factors, and most stroke cases (71%) involved carotid territory on the same side of the embolus.
9. Mitchell P, Wang JJ, Li W, Leeder SR, Smith W: Prevalence of asymptomatic retinal emboli in an Australian urban community. Stroke 1997, 28:63-66. This article is important because it is the first large prospective study aimed to assess prevalence and associations of asymptomatic retinal emboli in a defined older population. Asymptomatic retinal emboli were found in 1.4% of 3654 asymptomatic Australian persons aged 49 years or older. Eighty percent of the emboli were cholesterol type. This study provides accurate prevalence rates for asymptomatic retinal emboli in the elderly and confirms associations with hypertension, smoking, and vascular disease.
10. O'Donnell BA, Mitchell P: The clinical features and associations of retinal emboli. Aust N Z J Ophthalmol 1992, 20:11-17.
11. Miller NR: Embolic causes of transient monocular visual loss: appearance, source and assessment. Ophthalmol Clin North Am 1996, 9:359-380. This is a comprehensive review of the appearance and sources of retinal emboli. Evaluation of these patients as well as their management is briefly discussed for each category of embolus.
12. Heinzlef O, Cohen A, Amarenco P: An update on aortic causes of ischemic stroke. Curr Opin Neurol 1997, 10:64-72. This article reviews all the studies showing that atherosclerotic disease of the aortic arch is an independent risk factor for ischemic stroke and a strong marker for recurrent vascular events. This location of atherosclerotic disease mainly involves patients older than 60 years. Its diagnosis is easy with transesophageal echocardiography, which is accurate, safe, and well-tolerated for the examination of the aortic arch, even in elderly patients. Treatment remains undetermined, but controlled therapeutic trials are about to start.
13. Streifler JY, Eliaziw M, Benavente OR, Harbison JW, Hachinski VC, Barnett HJM, Simard D; for the North American Symptomatic Carotid Endarterectomy Trial: The risk of stroke in patients with first-ever retinal vs hemispheric transient ischemic attacks and high grade stenosis. Arch Neurol 1995, 52:246-249. This substudy of the North American Symptomatic Carotid Endarterectomy Trial (NASCET) provides important information about the prognosis of patients presenting with transient monocular visual loss related to high-grade internal carotid artery stenosis. The authors identified 129 medically treated patients with 70%-99% stenosis of the internal carotid artery who had their first transient ischemic attack as the entry event into the trial. Fifty-nine patients with transient monocular visual loss (TMVL) were compared with 70 patients with hemispheric transient ischemic attack (TIA). On aspirin alone, the risk of cerebral infarction at 2 years was 16.6% ± 5.6% for the patients with TMVL and 43.5% ± 6.7% for patients with TIAs. Risks increased with severity of stenosis for both.
14. Furlan AJ, Whisnant JP, Kearns TP: Unilateral visual loss in bright light: an unusual symptom of carotid artery disease. Ophthalmology 1984, 91:1631-1633.
15. Stiris T, Ruud Hansen TW, Odden JP, Morkrid L, Bratlid D: Effect of light and hyperoxia on ocular blood flow in the newborn piglet. Biol Neonate 1989, 55:191-196.
16. Levin LA, Mootha V: Postprandial transient visual loss: a symptom of critical carotid stenosis. Ophthalmology 1997, 104:397-401. Detailed clinical and radiologic description of two patients with severe carotid artery occlusive disease and transient visual loss occurring after eating a meal. The authors provide a good discussion of the pathophysiology of hemodynamic transient visual loss.
17. Ross Russell RW, Page NGR: Critical perfusion of the brain and retina. Brain 1983, 106:419-427.
18. Kerty E, Horven I: Ocular hemodynamics changes in patients with high-grade carotid occlusive disease and development of chronic ocular ischaemia. I. Doppler and dynamic tonometry findings. Acta Ophthalmol Scand 1995, 73:66-71. Transorbital ultrasonography is an easy and reproducible way to study blood flow within the opthalmic artery. In this study of 45 consecutive patients with hemodynamically significant carotid occlusive disease, the authors were able to demonstrate a good correlation between ischemic oculopathy and retrograde flow in the ophthalmic artery. They also suggested that the occurrence of retrograde ophthalmic artery flow may be the main determinant with regards to development of chronic ocular ischemic changes.
19. Kerty E, Eide N, Horven I: Ocular hemodynamic changes in patients with high-grade carotid occlusive disease and development of chronic ocular ischaemia. II. Clinical findings. Acta Ophthalmol Scand 1995, 73:72-76. The authors present the clinical characteristics of these 45 consecutive patients with severe (≥75%) carotid occlusive disease studied with transorbital ultrasonography. Clinical evidence of ischemic oculopathy was found in 32 patients, among whom 9 had fully developed typical chronic ocular ischemia.
20. Kline B: The natural history of patients with amaurosis fugax. Ophthalmol Clin North Am 1996, 9:351-357. This is a review of the frequency and mechanisms of vascular complications (both ocular and cerebral) occurring in patients with transient monocular visual loss.
21. American Heart Association Medical/Scientific Statement. Guidelines for the management of patients with transient ischemic attacks. Stroke 1994, 25:1320-1335. This is a comprehensive review about the diagnosis and management of patients with transient ischemic attacks (including retinal and cerebral).
22. •] and therefore should be interpreted more cautiously as regards to surgical indications for asymptomatic carotid artery stenosis.
23. Brown GC, Green WR: The ocular ischemic syndrome. Curr Opin Ophthalmol 1994, 5:14-20. Clinical characteristics and mechanisms of ocular ischemic syndrome are reviewed.
24. Karwatowski WSS, Jampol LM, Mani H, Weinreb RN: Neovascular glaucoma in Takayashu's disease: a case report. Retina 1995, 15:353-354.
25. Mizener JB, Podhajsky P, Hayreh SS: Ocular ischemic syndrome. Ophthalmology 1997, 104:859-864. The authors reviewed the clinical features of 32 patients (39 eyes) with ischemic ocular syndrome. They discuss the pathophysiology of this disease as well as its management.
26. Nguyen QH, Hamed LM, Sherwood MB, Roseman RL: Neovascular glaucoma after carotid endarterectomy. Ophthalmic Surg Lasers 1996, 27:881-884.
27. Mawn LA, Hedges III TR, Rand W, Heggerick PA: Orbital color Doppler imaging in carotid occlusive disease. Arch Ophthalmol 1997, 115:492-496.
28. Geroulakos G, Botchway LT, Pai V, Wilkinson AR, Galloway JM: Effect of carotid endarterectomy on the ocular circulation and on ocular symptoms unrelated to emboli. Eur J Vasc Endovasc Surg 1996, 3:359-363.
29. Droy-Lefaix MT, Szabo ME, Doly M: Ischaemia and reperfusion-induced injury in rat retina obtained from normotensive and spontaneously hypertensive rats: effect of free radicals scavengers. Int J Tissue React 1993, 15:85-91.
30. Cullom RD, Cullom ME: Two neuro-ophthalmic episodes separated in time and space. Surv Ophthalmol 1995, 40:217-224.
31. Hayreh SS: Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations and management. Ophthalmol Clin North Am 1996, 9:407-442. A recent comprehensive review of ischemic optic neuropathies by Hayreh.
32. Hayreh SS, Joos KM, Podhajsky PA, Long CR: Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994, 118:766-780. This is a prospective study of the prevalence of various systemic diseases in 406 patients with nonarteritic anterior ischemic optic neuropathy. Information on carotid artery disease was available in 63 patients, and of these, 10 patients had plaques only, 20 had stenosis of the internal carotid artery (percent stenosis not detailed), and 33 were normal. However, the group with carotid evaluation was not a random sample and is, therefore, likely to overestimate somewhat the prevalence of carotid artery disease in nonarteritic anterior ischemic optic neuropathy.
33. Horton JC: Embolic cilioretinal artery occlusion with atherosclerosis of the ipsilateral carotid artery. Retina 1995, 15:441-444. The two patients described in this report had embolic cilioretinal artery occlusion and atheromatous disease of their ipsilateral carotid artery, and support the debated theory of "embolic anterior ischemic optic neuropathy" (AION). Because the short posterior ciliary arteries also perfuse the optic disc, the author suggests that emboli from the carotid artery can also occasionally produce AION by occluding the blood supply to the optic disc.
34. Biousse V, Schaison M, Bousser MG: Ischemic optic neuropathy in spontaneous extracranlal dissections of internal carotid artery [abstract]. Neuro-Ophthalmology 1996, 16(suppl): 272.
35. Jacobson DM, Warner J, Broste SK: Optic nerve contact and compression by the carotid artery in asymptomatic patients. Am J Ophthalmol 1997, 123:677-683. This is a retrospective study of 100 asymptomatic patients who had undergone MR imaging with sequences that could be used to evaluate the relation between the intracranial optic nerve and the supraclinoid internal carotid artery. Seventy percent of patients had contact of one or both optic nerves with the carotid artery, 12% had bilateral compression of the optic nerve while only 5% had unilateral compression. The risk of compression was directly proportional to the diameter of the carotid artery.
36. Golinik KC, Hund PW, Stroman GA, Steward WC: Magnetic resonance imaging in patients with unexplained optic neuropathy. Ophthalmology 1996, 103:515-20.
37. Gutman I, Melamed S, Ashkenasi I, Blumenthal M: Optic nerve compression by carotid arteries in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1993, 231:711-717.
38. Colapinto EV, Cabeen MA, Johnson LN: Optic nerve compression by a dolichoectatic internal carotid artery: case report Neurosurgery 1996, 39:604-606.
39. Biousse V, D'Anglejan-Chatillon J, Touboul PJ, Amarenco P, Bousser MG: Time course of symptoms in extracranial carotid artery dissections. Stroke 1995, 26:235-239.
40. Biousse V, D'Anglejan-Chatillon J, Massiou H, Bousser MG: Head pain in non-traumatic carotid artery dissection: a series of 65 patients. Cephalalgia 1994, 14:33-36.
41. Bilbao R, Amoros S, Murube J: Horner's syndrome as an isolated manifestation of an intrapetrous internal carotid artery dissection. Am J Ophthalmol 1997, 123:562-564.
42. Wilson WB, Leavengood JM, Ringel SP, Bott AD: Transient oculomotor paresis associated with acute internal carotid artery occlusion. Ann Neurol 1989, 25:286-290.
43. Vargas ME, Desrouleaux JR, Kupersmith MJ: Ophthalmoplegia as a presenting manifestation of internal carotid artery dissection. J Clin Neuroophthalmol 1992, 12:268-271.
44. Mokri B, Silbert PL, Schievink WI, Piepgras DG: Cranial nerve palsy in spontaneous dissection of the extracranial internal carotid artery. Neurology 1996, 46:356-359. This is a retrospective study of cranial nerve palsy in spontaneous dissection of the extracranial internal carotid artery. Cranial nerve palsy was present in 23 of 190 consecutive patients, among whom five had oculomotor palsy (two third nerve palsy, two sixth nerve palsy, one fourth nerve palsy). Associated symptoms included headache in all five patients, Horner's in two, and sixth nerve involvement in one. Mechanisms of these cranial nerve palsies from carotid dissection are discussed.
45. Lapresle J, Lasjaunias P: Cranial nerve ischaemic arterial syndromes: a review. Brain 1986, 109:207-216.
46. Newman NJ: Evaluating the patient with transient monocular vision loss: the young versus the elderly. Ophthalmol Clin North Am 1996, 9:455-465. A review of the assessment and management of patients with transient monocular vision loss depending on their age and associated diseases.
47. Sellar RJ: Imaging blood vessels of the head and neck. J Neurol Neurosurg Psych 1995, 59:225-237.
48. Karanjia PN, Jacobson DM: Angiography in transient monocular visual loss. Ophthalmol Clin North Am 1996, 9:473-489.
49. Brown J, Danielson R, Donahue SP, Thompson HS: Horner's syndrome in subadventitial carotid artery dissection and the role of magnetic resonance angiography. Am J Ophthalmol 1995, 6:811-813.